Europe Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Clinical Indication, Functionality, Application, and End User

List of Tables

The Europe pharmaceutical excipients market is expected to grow from US$ 2,878.05 million in 2022 to US$ 4,198.83 million by 2028. It is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

Growing Generics is Driving the Growth of Europe pharmaceutical excipients market

Governments of developing countries are focusing on reducing healthcare costs by boosting the production of generic drugs. In addition, many drugs are on the brink of losing their patents. Generic drug companies can produce replicas of branded drugs when patents of original drugs expire. The replicas can cost up to 80% less than the originals. Therefore, the generics industry has witnessed remarkable growth in the last decade as the patents of many branded drugs have expired, with companies achieving above-average shareholder returns. Excipients are an integral component of pharmaceutical products that determine the structure of dosage type and its role in delivering drugs. Excipients significantly affect the processability, aesthetics, efficiency, and patient compliance with the dosage form. The principal role of excipients is to support patient acceptability, enhance stability and bioavailability, and assist in effectiveness. Thus, the rise in the sale of generic drugs across the region propels the demand for pharmaceutical excipients used in manufacturing generic drugs.

Europe Pharmaceutical Excipients Market Overview

Europe is in the second position in the global market for pharmaceutical excipients and is expected to register a high growth rate during the forecast period. The pharmaceutical excipients market in Europe is in a growth phase due to the presence of the scientific guidelines of the European Medicines Agency for excipients, which enable the planning of marketing authorization applications for medicines for human consumption. The research-based pharmaceutical industry can play a key role in restoring growth in Europe and ensuring future competitiveness in the global economy. Moreover, the increasing prevalence of chronic diseases is fueling the growth of the Europe pharmaceutical excipients market . Technological advancements in the formulation of medicines with the help of excipients are boosting the market growth in the country. Pharmaceutical companies are launching excipients as a stabilization aid for biologics. In April 2020, DFE PHARMA launched the first in this BioHale range; with BioHale, the new excipient portfolio for biologics, DFE Pharma offers the highest purity excipients to be used in the formulation. Additionally, in June 2019, DFE Pharma, a global excipient supplier of the pharmaceutical industry, announced the US launch of their excipient eStore. This new e-commerce channel enabled pharmaceutical, biotech, and nutraceutical companies to order small quantities of GMP materials delivered fast to their doorstep.

Europe Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

Europe Pharmaceutical Excipients Market Segmentation

The Europe pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country.

Based on type, the Europe pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

Based on clinical indication, the Europe pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the Europe pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the Europe pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the Europe pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the Europe pharmaceutical excipients market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the Europe pharmaceutical excipients market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe pharmaceutical excipients market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00022813

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Pharmaceutical Excipients Market - By Type
- 1.3.2 Europe Pharmaceutical Excipients Market - By Clinical Indication
- 1.3.3 Europe Pharmaceutical Excipients Market - By Functionality
- 1.3.4 Europe Pharmaceutical Excipients Market - By Application
- 1.3.5 Europe Pharmaceutical Excipients Market - By End User
- 1.3.6 Europe Pharmaceutical Excipients Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Pharmaceutical Excipients Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Pharmaceutical Excipients Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing Generics Market
- 5.1.2 Increasing Product Launches
5.2 Market Restraints
- 5.2.1 Cost and Time-Intensive Drug Development Process
5.3 Market Opportunities
- 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
5.4 Future Trends
- 5.4.1 Use of Nanotechnology to Improve Excipients Capabilities
5.5 Impact Analysis

6. Pharmaceutical Excipients Market - Global Analysis

6.1 Europe Pharmaceutical Excipients Market Revenue Forecast & Analysis

7. Europe Pharmaceutical Excipients Market Analysis - By Type

7.1 Overview
7.2 Europe Pharmaceutical Excipients Market, By Type, 2021 & 2028 (%)
7.3 Bioresorbable Polymers & Lipids & Liposome-Based Formulation
- 7.3.1 Overview
- 7.3.2 Bioresorbable Polymers & Lipids & Liposome-Based Formulation: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oleochemicals
- 7.4.1 Overview
- 7.4.2 Oleochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.1 Fatty Alcohols
    - 7.4.2.1.1 Overview
    - 7.4.2.1.2 Fatty Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.2 Metal Stearates
    - 7.4.2.2.1 Overview
    - 7.4.2.2.2 Metal Stearates: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.3 Glycerine
    - 7.4.2.3.1 Overview
    - 7.4.2.3.2 Glycerine: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.4.2.4 Others
    - 7.4.2.4.1 Overview
    - 7.4.2.4.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Sugars
- 7.5.1 Overview
  - 7.5.1.1 Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.2 Actual Sugars
    - 7.5.1.2.1 Overview
    - 7.5.1.2.2 Actual Sugars: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.3 Sugar Alcohols
    - 7.5.1.3.1 Overview
    - 7.5.1.3.2 Sugar Alcohols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.5.1.4 Artificial Sweeteners
    - 7.5.1.4.1 Overview
    - 7.5.1.4.2 Artificial Sweeteners: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Cellulose
- 7.6.1 Overview
- 7.6.2 Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.1 Microcrystalline Cellulose
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Microcrystalline Cellulose: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.2 Cellulose Ethers
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Cellulose Ethers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.6.2.3 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium
    - 7.6.2.3.1 Overview
    - 7.6.2.3.2 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Starches
- 7.7.1 Overview
- 7.7.2 Starches: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.1 Modified Starch
    - 7.7.2.1.1 Modified Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.2 Dried Starch
    - 7.7.2.2.1 Dried Starch: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.7.2.3 Converted Starch and Pregelatinized Starch
    - 7.7.2.3.1 Carboxymethyl Cellulose (CMC) and Croscarmellose Sodium: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.8 Petrochemicals
- 7.8.1 Overview
- 7.8.2 Petrochemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.1 Glycols
    - 7.8.2.1.1 Glycols: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.2 Povidones
    - 7.8.2.2.1 Povidones: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.3 Mineral Hydrocarbons
    - 7.8.2.3.1 Mineral Hydrocarbons: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.8.2.4 Others
    - 7.8.2.4.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.9 Plant Proteins and Polyols and Cyclodextrins
- 7.9.1 Overview
- 7.9.2 Plant Proteins and Polyols and Cyclodextrins: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.10 Inorganic Chemicals
- 7.10.1 Overview
- 7.10.2 Inorganic Chemicals: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.1 Magnesium and Calcium Carbonate
    - 7.10.2.1.1 Magnesium and Calcium Carbonate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.2 Calcium and Aluminium Phosphate
    - 7.10.2.2.1 Calcium and Aluminium Phosphate: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.3 Silicon Dioxide
    - 7.10.2.3.1 Silicon Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.4 Titanium Dioxide
    - 7.10.2.4.1 Titanium Dioxide: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
  - 7.10.2.5 Others
    - 7.10.2.5.1 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Clinical Indication

8.1 Overview
8.2 Europe Pharmaceutical Excipient Market, By Clinical Indication, 2021 & 2028 (%)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Metabolic
- 8.4.1 Overview
- 8.4.2 Metabolic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Infectious Disease
- 8.5.1 Overview
- 8.5.2 Infectious Disease: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Dental
- 8.6.1 Overview
- 8.6.2 Dental: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Ophthalmic
- 8.7.1 Overview
- 8.7.2 Ophthalmic: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Gene Therapies
- 8.8.1 Overview
- 8.8.2 Gene Therapies: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

9. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Functionality

9.1 Overview
9.2 Europe Pharmaceutical Excipient Market, By Functionality, 2021 & 2028 (%)
9.3 Coloring Agents and Coating Agents
- 9.3.1 Overview
- 9.3.2 Coloring Agents and Coating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Sweetener and Flavoring Agents
- 9.4.1 Overview
- 9.4.2 Sweetener and Flavoring Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Suspending and Viscosity Agents
- 9.5.1 Overview
- 9.5.2 Suspending and Viscosity Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.6 Preservative and Controlled Release
- 9.6.1 Overview
- 9.6.2 Preservative and Controlled Release: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.7 Antioxidant and Oil
- 9.7.1 Overview
- 9.7.2 Antioxidant and Oil: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.8 Tablet Filler and Diluents
- 9.8.1 Overview
- 9.8.2 Tablet Filler and Diluents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.9 Binders and Compression and Granulating Agents
- 9.9.1 Overview
- 9.9.2 Binders and Compression and Granulating Agents: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.10 Emulsifiers
- 9.10.1 Overview
- 9.10.2 Emulsifiers: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
9.11 Others
- 9.11.1 Overview
- 9.11.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

10. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By Application

10.1 Overview
10.2 Europe Pharmaceutical Excipient Market, By Application, 2021 & 2028 (%)
10.3 Parenteral
- 10.3.1 Overview
- 10.3.2 Parenteral: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Oral Formulations & Tablets
- 10.4.1 Overview
- 10.4.2 Oral Formulations & Tablets: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Capsules
- 10.5.1 Overview
- 10.5.2 Capsules: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.3 Hard Gels
  - 10.5.3.1 Overview
  - 10.5.3.2 Hard Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.4 Soft Gels
  - 10.5.4.1 Overview
  - 10.5.4.2 Soft Gels: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Liquid & Injectable
- 10.6.1 Overview
- 10.6.2 Liquid & Injectable: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Physiochemical Excipient-Container Interactions in Prefilled Syringes
- 10.7.1 Overview
- 10.7.2 Physiochemical Excipient-Container Interactions in Prefilled Syringes: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.8 Nutraceutical & OTC
- 10.8.1 Overview
- 10.8.2 Nutraceutical & OTC: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.9 Topical
- 10.9.1 Overview
- 10.9.2 Topical: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
10.10 Others
- 10.10.1 Overview
- 10.10.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

11. Europe Pharmaceutical Excipients Market Analysis and Forecasts To 2028 - By End User

11.1 Overview
11.2 Europe Pharmaceutical Excipient Market, By End User, 2021 & 2028 (%)
11.3 Biopharma Industries
- 11.3.1 Overview
- 11.3.2 Biopharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Pharma Industries
- 11.4.1 Overview
- 11.4.2 Pharma Industries: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Animal Health
- 11.5.1 Overview
- 11.5.2 Animal Health: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: Pharmaceutical Excipient Market Revenue and Forecasts to 2028 (US$ Million)

12. Europe Pharmaceutical Excipients Market Revenue and Forecasts to 2028 - Country Analysis

12.1 Overview
- 12.1.1 Europe: Pharmaceutical Excipients Market, by Country, 2021 & 2028 (%)
  - 12.1.1.1 UK: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 UK: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.1.3 UK: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.1.3.1 UK: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.1.3.2 UK: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.1.3.3 UK: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.1.3.4 UK: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.1.3.5 UK: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.1.3.6 UK: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.1.4 UK: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.1.5 UK: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.1.6 UK: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.1.6.1 UK: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.1.7 UK: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.1.2 Germany: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 Germany: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.2.3 Germany: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.2.3.1 Germany: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.2.3.2 Germany: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.2.3.3 Germany: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.2.3.4 Germany: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.2.3.5 Germany: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.2.3.6 Germany: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.2.4 Germany: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.2.5 Germany: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.2.6 Germany: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.2.6.1 Germany: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.2.7 Germany: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.1.3 France: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 France: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.3.3 France: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.3.3.1 France: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.3.3.2 France: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.3.3.3 France: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.3.3.4 France: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.3.3.5 France: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.3.3.6 France: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.3.4 France: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.3.5 France: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.3.6 France: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.3.6.1 France: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.3.7 France: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.1.4 Italy: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.4.1 Overview
    - 12.1.1.4.2 Italy: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.4.3 Italy: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.4.3.1 Italy: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.4.3.2 Italy: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.4.3.3 Italy: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.4.3.4 Italy: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.4.3.5 Italy: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.4.3.6 Italy: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.4.4 Italy: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.4.5 Italy: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.4.6 Italy: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.4.6.1 Italy: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.4.7 Italy: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.1.5 Spain: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.5.1 Overview
    - 12.1.1.5.2 Spain: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.5.3 Spain: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.5.3.1 Spain: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.5.3.2 Spain: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.5.3.3 Spain: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.5.3.4 Spain: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.5.3.5 Spain: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.5.3.6 Spain: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.5.4 Spain: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.5.5 Spain: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.5.6 Spain: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.5.6.1 Spain: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.5.7 Spain: Pharmaceutical Excipients Market, by End User, 2019-2028
  - 12.1.1.6 Rest of Europe: Pharmaceutical Excipients Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.6.1 Overview
    - 12.1.1.6.2 Rest of Europe: Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.6.3 Rest of Europe: Pharmaceutical Excipients Market, by Type, 2019-2028
    - 12.1.1.6.3.1 Rest of Europe: Pharmaceutical Excipients Market, by Oleochemicals, 2019-2028
    - 12.1.1.6.3.2 Rest of Europe: Pharmaceutical Excipients Market, by Sugars, 2019-2028
    - 12.1.1.6.3.3 Rest of Europe: Pharmaceutical Excipients Market, by Cellulose, 2019-2028
    - 12.1.1.6.3.4 Rest of Europe: Pharmaceutical Excipients Market, by Starches, 2019-2028
    - 12.1.1.6.3.5 Rest of Europe: Pharmaceutical Excipients Market, by Petrochemicals, 2019-2028
    - 12.1.1.6.3.6 Rest of Europe: Pharmaceutical Excipients Market, by Inorganic Chemicals, 2019-2028
    - 12.1.1.6.4 Rest of Europe: Pharmaceutical Excipients Market, by Clinical Indication, 2019-2028
    - 12.1.1.6.5 Rest of Europe: Pharmaceutical Excipients Market, by Functionality, 2019-2028
    - 12.1.1.6.6 Rest of Europe: Pharmaceutical Excipients Market, by Application, 2019-2028
    - 12.1.1.6.6.1 Rest of Europe: Pharmaceutical Excipients Market, by Capsules, 2019-2028
    - 12.1.1.6.7 Rest of Europe: Pharmaceutical Excipients Market, by End User, 2019-2028

13. Europe Pharmaceutical Excipients Market-Industry Landscape

13.1 Overview
13.2 Organic Developments
- 13.2.1 Overview
13.3 Inorganic Developments
- 13.3.1 Overview

14. Company Profile

14.1 JRS PHARMA GmbH & Co. KG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Roquette Freres SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 BASF SE
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Evonik Industries AG
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 AshLand Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Archer-Daniels-Midland Co
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 The Dow Chemical Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 The Lubrizol Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Avantor Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 MEGGLE GmbH & Co KG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms